Page 103 | Certara

Blog

5 Steps to Satisfy New EU-CTR Requirements for Plain Language Summaries of Clinical Study Results

For the first time, the European Medicines Agency (EMA) has passed new regulations to help…

CertaraSeptember 27, 2022

Business transparency, integrity or data disclosure concept, businessman standing with disclosure financial document in crystal clear fish bowl

Blog

EU-CTR Challenges Drug Developers Faced in the First 6 Months

Under European Union Clinical Trial Regulation 536/2014 (EU-CTR), replacing the EU Clinical Trial Directive (Directive…

CertaraSeptember 26, 2022

Podcast

Certara – Improving Investment in Drug Development through Biosimulation

CertaraSeptember 23, 2022

On-Demand Webinar

Optimize drug development with public data and predictive models – model-based meta-analysis (MBMA)

Properly understanding the probability of successful drug development requires utilization of all available information. Critical…

CertaraSeptember 23, 2022

Blog

3 Takeaways from the FDA Oligo Guidance You Need to Know

In June 2022, the FDA published their first oligonucleotide clinical pharmacology specific guidance . This…

CertaraSeptember 23, 2022

On-Demand Webinar

Pinnacle 21 Data Exchange: Transforming External Vendor Data Management

The volume and complexity of clinical data are growing at a faster pace than the…

CertaraSeptember 19, 2022

Fact Sheet

Accelerating Pediatric Drug Development with Biosimulation and Regulatory Science

CertaraSeptember 13, 2022

Press Coverage

Certara Hosts Seminar on Drug Discovery Challenges in Japan and How Modeling and Simulation Can Solve Them

“Quantitative decision-making with data rather than empirical thinking" - Certara's Modeling & Simulation technology contributes…

CertaraSeptember 13, 2022

On-Demand Webinar

Navigating the Biotech Funding Crunch: How to Achieve Your Next Value Inflection

For the past two years, the biotech sector saw a surge of venture funding and…

CertaraAugust 30, 2022

Blog

3 Major Implications of New European Clinical Trial Regulations

Have you heard the buzz around the new European Union Clinical Trial Regulations (EU-CTR) for…

CertaraAugust 25, 2022

5 Steps to Satisfy New EU-CTR Requirements for Plain Language Summaries of Clinical Study Results

EU-CTR Challenges Drug Developers Faced in the First 6 Months

Certara – Improving Investment in Drug Development through Biosimulation

Optimize drug development with public data and predictive models – model-based meta-analysis (MBMA)

3 Takeaways from the FDA Oligo Guidance You Need to Know

Pinnacle 21 Data Exchange: Transforming External Vendor Data Management

Accelerating Pediatric Drug Development with Biosimulation and Regulatory Science

Certara Hosts Seminar on Drug Discovery Challenges in Japan and How Modeling and Simulation Can Solve Them

Navigating the Biotech Funding Crunch: How to Achieve Your Next Value Inflection

3 Major Implications of New European Clinical Trial Regulations

Newsletter sign up

Quick links

Solutions

Contact